News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Florian Scotté: Mascc and Gustave Roussy support Lety and Olivier around the world
Photo taken from 8milliardsdesourires.fr
Aug 11, 2024, 11:56

Florian Scotté: Mascc and Gustave Roussy support Lety and Olivier around the world

Florian Scotté, Head of the Interdisciplinary Patient Pathway Organization Department (DIOPP) at Gustave Roussy, posted on LinkedIn:

“Mascc and Gustave Roussy support Lety and Olivier around the world. After Miami they arrive in South America, today Colombia.”

Additional information.
Source: Florian Scotté/LinkedIn

cancer Florian Scotte Gustave Roussy Mascc Roussy OncoDaily Oncology
Blog
Aug 11, 2024, 11:56
Florian Scotté: Mascc and Gustave Roussy support Lety and Olivier around the world
Blog
Aug 11, 2024, 11:55
Danielle Carniva: Biden Cancer Moonshot and the Government of India convened discussion to address challenges in cancer
Insight
Aug 11, 2024, 11:48
Arif Kamal: Big News from ACS CARES
Blog
Aug 11, 2024, 11:43
New York Proton Center celebrates treating over 5,000 patients
Insight
Aug 11, 2024, 11:41
Hung Trinh: A rapid establishment for CAR T Cell Therapy Treatment Center Locator
Societies
Aug 11, 2024, 11:33
Hope For Stomach Cancer joined the Amgen Advocacy Stakeholder Summit along with more than 70 organizations
Blog
Aug 11, 2024, 10:29
The intratumoral microbiome in lung cancer
Blog
Aug 11, 2024, 10:17
Carl June about the potential of using CAR T therapy to treat glioblastoma - Penn Medicine
Career
Aug 11, 2024, 10:06
Jill Barnholtz-Sloan: Job and fellow opportunities at NCICBIIT
Blog
Aug 11, 2024, 09:37
Ruben A. Mesa: Proud of these top Docs delivering world class cancer care
Positive
Aug 11, 2024, 08:55
Matthias Heinzel: It’s in our DNA
Insight
Aug 11, 2024, 08:42
Susumu Kobayashi: The importance of BCL-XL during emergence of resistance to EGFR TKIs